HK Stock MarketDetailed Quotes

02415 MEDSCI

Watchlist
  • 0.870
  • 0.0000.00%
Market Closed Dec 13 16:08 CST
528.24MMarket Cap11.15P/E (TTM)

MEDSCI Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax
-101.86%-240K
162.78%60.45M
111.99%12.89M
34.52%-96.29M
---107.45M
-543.31%-147.06M
77.18%33.17M
--18.72M
Profit adjustment
Interest (income) - adjustment
-71.57%-10.32M
-48.10%-15.37M
-40.11%-6.01M
-114.22%-10.38M
---4.29M
-229.82%-4.85M
-48.08%-1.47M
---992K
Impairment and provisions:
-9.27%519K
437.33%13.62M
-82.68%572K
-61.04%2.53M
--3.3M
1,182.84%6.5M
71.86%507K
--295K
-Impairment of trade receivables (reversal)
83.75%-52K
-121.88%-35K
-321.05%-320K
-76.23%160K
---76K
286.78%673K
17.57%174K
--148K
-Other impairments and provisions
-35.99%571K
475.02%13.65M
-73.59%892K
-59.29%2.37M
--3.38M
1,651.05%5.83M
126.53%333K
--147K
Revaluation surplus:
46.82%-7.39M
---6.97M
---13.9M
----
----
19,239.56%190.63M
-107.93%-996K
---479K
-Other fair value changes
46.82%-7.39M
---6.97M
---13.9M
----
----
19,239.56%190.63M
-107.93%-996K
---479K
Asset sale loss (gain):
----
----
----
----
----
---836K
----
----
-Loss (gain) from sale of subsidiary company
----
----
----
----
----
---836K
----
----
Depreciation and amortization:
-0.90%3.96M
-0.33%8.35M
-8.44%3.99M
-1.16%8.38M
--4.36M
19.30%8.48M
9.61%7.11M
--6.48M
-Amortization of intangible assets
285.71%432K
738.46%654K
--112K
--78K
----
----
----
----
Financial expense
-42.48%88K
-22.69%276K
-0.65%153K
31.73%357K
--154K
-35.63%271K
-7.47%421K
--455K
Special items
418.34%16.53M
-106.41%-7.42M
-96.64%3.19M
1,319.31%115.69M
--94.82M
--8.15M
----
----
Operating profit before the change of operating capital
258.09%3.14M
160.93%52.93M
109.65%878K
-66.90%20.29M
---9.1M
58.21%61.29M
58.23%38.74M
--24.48M
Change of operating capital
Accounts receivable (increase)decrease
11.68%9.22M
136.52%2.99M
831.60%8.25M
36.18%-8.19M
--886K
-794.63%-12.83M
85.63%-1.43M
---9.98M
Accounts payable increase (decrease)
219.10%1.95M
254.44%8.07M
-219.81%-1.64M
-127.13%-5.23M
--1.37M
-45.47%19.27M
30.85%35.33M
--27M
prepayments (increase)decrease
-573.03%-22.53M
88.41%-623K
81.71%-3.35M
-66.26%-5.38M
---18.31M
-225.35%-3.23M
78.00%-994K
---4.52M
Special items for working capital changes
212.43%8.4M
-129.15%-37.5M
42.10%-7.47M
52.71%-16.36M
---12.91M
-219.76%-34.6M
-31.27%-10.82M
---8.24M
Cash  from business operations
105.47%182K
274.01%25.88M
91.26%-3.33M
-149.74%-14.87M
---38.06M
-50.85%29.89M
111.60%60.82M
--28.75M
Other taxs
-40.51%-4.51M
66.39%-3.21M
64.66%-3.21M
-465.66%-9.55M
---9.08M
142.87%2.61M
-1,692.06%-6.09M
---340K
Interest received - operating
71.57%10.32M
48.10%15.37M
40.11%6.01M
114.22%10.38M
--4.29M
229.82%4.85M
48.08%1.47M
--992K
Net cash from operations
1,242.75%5.99M
370.87%38.04M
98.78%-524K
-137.59%-14.04M
---42.85M
-33.54%37.35M
91.18%56.2M
--29.4M
Cash flow from investment activities
Loan receivable (increase) decrease
----
--250K
--250K
----
----
----
--1.05M
----
Decrease in deposits (increase)
---280.29M
---4.25M
----
----
----
----
----
----
Sale of fixed assets
--16K
----
----
--31K
----
----
----
----
Purchase of fixed assets
-18.82%-202K
65.13%-181K
41.38%-170K
41.62%-519K
---290K
19.98%-889K
-513.81%-1.11M
---181K
Purchase of intangible assets
61.29%-144K
-7.60%-1.77M
---372K
---1.65M
----
----
----
----
Sale of subsidiaries
----
----
----
----
----
---1.15M
----
----
Recovery of cash from investments
--217.67M
--299.32M
----
----
----
----
--31.48M
----
Cash on investment
38.54%-231.01M
---788.35M
---375.87M
----
----
----
----
---30M
Net cash from investment operations
21.85%-293.96M
-23,105.53%-494.97M
-129,611.72%-376.16M
-4.87%-2.13M
---290K
-106.47%-2.03M
204.09%31.41M
---30.18M
Net cash before financing
23.55%-287.97M
-2,724.96%-456.94M
-773.24%-376.69M
-145.80%-16.18M
---43.14M
-59.69%35.32M
11,275.26%87.61M
---784K
Cash flow from financing activities
Issuing shares
----
--519.86M
--519.86M
----
----
--297.1M
----
----
Absorb investment income
----
----
----
--100K
--100K
----
--100M
----
Issuance expenses and redemption of securities expenses
---171K
---42.01M
----
----
----
----
----
----
Other items of the financing business
--1.38M
----
----
----
----
---3.88M
----
----
Net cash from financing operations
-100.30%-1.54M
6,365.67%470.93M
11,979.48%516.4M
-102.63%-7.52M
---4.35M
206.75%285.56M
1,629.59%93.09M
---6.09M
Effect of rate
-88.99%2.33M
-43.12%15.33M
10.42%21.17M
1,562.56%26.96M
--19.17M
-1,362.70%-1.84M
-250.00%-126K
--84K
Net Cash
-307.22%-289.51M
159.05%13.99M
394.23%139.71M
-107.38%-23.69M
---47.48M
77.57%320.87M
2,730.35%180.71M
---6.87M
Begining period cash
4.89%628.59M
0.55%599.27M
0.55%599.27M
115.18%596M
--596M
187.34%276.97M
-6.58%96.39M
--103.18M
Cash at the end
-55.09%341.4M
4.89%628.59M
33.90%760.15M
0.55%599.27M
--567.69M
115.18%596M
187.34%276.97M
--96.39M
Cash balance analysis
Cash and bank balance
-55.09%341.4M
4.89%628.59M
--760.15M
--599.27M
----
----
----
----
Cash and cash equivalent balance
-55.09%341.4M
4.89%628.59M
--760.15M
--599.27M
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
Ernst & Young
(Q6)Jun 30, 2024(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019
Cash flow from operating activities
Earning before tax -101.86%-240K162.78%60.45M111.99%12.89M34.52%-96.29M---107.45M-543.31%-147.06M77.18%33.17M--18.72M
Profit adjustment
Interest (income) - adjustment -71.57%-10.32M-48.10%-15.37M-40.11%-6.01M-114.22%-10.38M---4.29M-229.82%-4.85M-48.08%-1.47M---992K
Impairment and provisions: -9.27%519K437.33%13.62M-82.68%572K-61.04%2.53M--3.3M1,182.84%6.5M71.86%507K--295K
-Impairment of trade receivables (reversal) 83.75%-52K-121.88%-35K-321.05%-320K-76.23%160K---76K286.78%673K17.57%174K--148K
-Other impairments and provisions -35.99%571K475.02%13.65M-73.59%892K-59.29%2.37M--3.38M1,651.05%5.83M126.53%333K--147K
Revaluation surplus: 46.82%-7.39M---6.97M---13.9M--------19,239.56%190.63M-107.93%-996K---479K
-Other fair value changes 46.82%-7.39M---6.97M---13.9M--------19,239.56%190.63M-107.93%-996K---479K
Asset sale loss (gain): -----------------------836K--------
-Loss (gain) from sale of subsidiary company -----------------------836K--------
Depreciation and amortization: -0.90%3.96M-0.33%8.35M-8.44%3.99M-1.16%8.38M--4.36M19.30%8.48M9.61%7.11M--6.48M
-Amortization of intangible assets 285.71%432K738.46%654K--112K--78K----------------
Financial expense -42.48%88K-22.69%276K-0.65%153K31.73%357K--154K-35.63%271K-7.47%421K--455K
Special items 418.34%16.53M-106.41%-7.42M-96.64%3.19M1,319.31%115.69M--94.82M--8.15M--------
Operating profit before the change of operating capital 258.09%3.14M160.93%52.93M109.65%878K-66.90%20.29M---9.1M58.21%61.29M58.23%38.74M--24.48M
Change of operating capital
Accounts receivable (increase)decrease 11.68%9.22M136.52%2.99M831.60%8.25M36.18%-8.19M--886K-794.63%-12.83M85.63%-1.43M---9.98M
Accounts payable increase (decrease) 219.10%1.95M254.44%8.07M-219.81%-1.64M-127.13%-5.23M--1.37M-45.47%19.27M30.85%35.33M--27M
prepayments (increase)decrease -573.03%-22.53M88.41%-623K81.71%-3.35M-66.26%-5.38M---18.31M-225.35%-3.23M78.00%-994K---4.52M
Special items for working capital changes 212.43%8.4M-129.15%-37.5M42.10%-7.47M52.71%-16.36M---12.91M-219.76%-34.6M-31.27%-10.82M---8.24M
Cash  from business operations 105.47%182K274.01%25.88M91.26%-3.33M-149.74%-14.87M---38.06M-50.85%29.89M111.60%60.82M--28.75M
Other taxs -40.51%-4.51M66.39%-3.21M64.66%-3.21M-465.66%-9.55M---9.08M142.87%2.61M-1,692.06%-6.09M---340K
Interest received - operating 71.57%10.32M48.10%15.37M40.11%6.01M114.22%10.38M--4.29M229.82%4.85M48.08%1.47M--992K
Net cash from operations 1,242.75%5.99M370.87%38.04M98.78%-524K-137.59%-14.04M---42.85M-33.54%37.35M91.18%56.2M--29.4M
Cash flow from investment activities
Loan receivable (increase) decrease ------250K--250K--------------1.05M----
Decrease in deposits (increase) ---280.29M---4.25M------------------------
Sale of fixed assets --16K----------31K----------------
Purchase of fixed assets -18.82%-202K65.13%-181K41.38%-170K41.62%-519K---290K19.98%-889K-513.81%-1.11M---181K
Purchase of intangible assets 61.29%-144K-7.60%-1.77M---372K---1.65M----------------
Sale of subsidiaries -----------------------1.15M--------
Recovery of cash from investments --217.67M--299.32M------------------31.48M----
Cash on investment 38.54%-231.01M---788.35M---375.87M-------------------30M
Net cash from investment operations 21.85%-293.96M-23,105.53%-494.97M-129,611.72%-376.16M-4.87%-2.13M---290K-106.47%-2.03M204.09%31.41M---30.18M
Net cash before financing 23.55%-287.97M-2,724.96%-456.94M-773.24%-376.69M-145.80%-16.18M---43.14M-59.69%35.32M11,275.26%87.61M---784K
Cash flow from financing activities
Issuing shares ------519.86M--519.86M----------297.1M--------
Absorb investment income --------------100K--100K------100M----
Issuance expenses and redemption of securities expenses ---171K---42.01M------------------------
Other items of the financing business --1.38M-------------------3.88M--------
Net cash from financing operations -100.30%-1.54M6,365.67%470.93M11,979.48%516.4M-102.63%-7.52M---4.35M206.75%285.56M1,629.59%93.09M---6.09M
Effect of rate -88.99%2.33M-43.12%15.33M10.42%21.17M1,562.56%26.96M--19.17M-1,362.70%-1.84M-250.00%-126K--84K
Net Cash -307.22%-289.51M159.05%13.99M394.23%139.71M-107.38%-23.69M---47.48M77.57%320.87M2,730.35%180.71M---6.87M
Begining period cash 4.89%628.59M0.55%599.27M0.55%599.27M115.18%596M--596M187.34%276.97M-6.58%96.39M--103.18M
Cash at the end -55.09%341.4M4.89%628.59M33.90%760.15M0.55%599.27M--567.69M115.18%596M187.34%276.97M--96.39M
Cash balance analysis
Cash and bank balance -55.09%341.4M4.89%628.59M--760.15M--599.27M----------------
Cash and cash equivalent balance -55.09%341.4M4.89%628.59M--760.15M--599.27M----------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified OpinionUnqualified Opinion
Auditor --Ernst & Young--Ernst & Young--Ernst & YoungErnst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
HK
Overall
Symbol
Price
% Chg

No Data